The Canadian drugmaker was already considering putting itself up for sale after an FDA advisory committee voted against recommending approval for the drug, Brinavess, used for atrial fibrillation.
Several years ago, Highmark began questioning its exclusive relationships with specialty pharmacies and started working with Free Market Health, which matches patients to the pharmacy…
Two hospital-at-home providers, DispatchHealth and Medically Home, announced their plan to merge. Once combined, the company will provide in-home care across 50 major metropolitan areas…
Welcome to Debunked, where we slaughter myths, bad practices and sacred cows in healthcare. In this episode, we talk about the turmoil in the federal…
Sarepta Therapeutics said the Duchenne muscular dystrophy patient recently had a cytomegalovirus infection, which can damage the liver and may have contributed to the fatality.…
The key to realizing the full potential of legacy systems in modern healthcare lies in overcoming interoperability challenges — ensuring seamless data exchange between various…
We need to embrace a more holistic, integrated approach to mental healthcare: one that combines the best of human expertise with rapid innovations of technology,…
Lantern has publicly released its methodology for calculating surgical savings, and is inviting others to do the same.
The American Cancer Society struck a multi-year collaboration with Layer Health, a healthcare AI company that uses LLMs to improve data abstraction and generate insights.…
AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of…
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
